• Founded in 2001
  • Employees: 450

Description :

Ablynx is engaged in the discovery and development of a novel class of therapeutic proteins, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease.

Headquarters :

Technologiepark 21 Zwijnaarde (Ghent), 9052 Belgium

Related Posts

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.